-
FDA Approves Signos Glucose Monitor for Weight Loss
The FDA has approved Signos’ glucose monitoring system for weight management, marking a first in the digital wellness space. Signos, a startup, offers a subscription service that includes glucose sensors and an app, which uses AI to provide personalized health insights. The system pairs with Dexcom’s Stelo CGM sensor patch, already available over the counter….
-
Community Health Workers Tackle ER Overcrowding
Hospitals are increasingly relying on community health workers to address potential emergency room overcrowding due to Medicaid cuts and changes to the Affordable Care Act. These workers assist patients in navigating insurance coverage, aiming to prevent a surge of uninsured individuals from overwhelming already busy emergency departments. The strategy comes as health systems brace for…
-
Biotech Firm Seeks Support After FDA Rejection
Stealth BioTherapeutics, a small biotech company, has taken the rare step of publicly sharing a rejection letter from the FDA. The company aims to gather support for its ultra-rare disease drug, which the FDA did not approve. This move highlights the challenges small biotechs face in gaining regulatory approval for niche treatments. By disclosing the…
-
Trump’s Bill Alters Immigrant Benefits Access
The One Big Beautiful Bill Act, introduced under President Trump, has changed how immigrants access federal benefits. The bill alters eligibility for programs like Medicare, Medicaid, CHIP, and SNAP based on immigration status. Notably, DACA recipients and some other immigrant groups have lost access to certain benefits. The Head Start program now limits eligibility to…
-
Maine Clinics Challenge Medicaid Funding Cuts
Maine Family Planning, a network of clinics, is seeking judicial intervention to restore Medicaid funding cut by a Trump administration policy. The policy blocks federal funds to abortion providers, impacting Maine Family Planning despite Medicaid not funding abortions. The clinics serve 8,000 low-income patients, offering services like cancer screenings and contraception. Without Medicaid, they risk…
-
Debate Over Obamacare Subsidies Intensifies
The debate over the future of Obamacare subsidies is heating up as Congress considers whether to extend the Biden administration’s enhanced subsidies, set to expire at the end of the year. These subsidies, introduced as temporary pandemic measures, have significantly reduced premiums for many, capping costs at 8.5% of income for exchange enrollees. However, critics…
